Daniel D. Bravo

997 total citations
5 papers, 57 citations indexed

About

Daniel D. Bravo is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel D. Bravo has authored 5 papers receiving a total of 57 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel D. Bravo's work include Phagocytosis and Immune Regulation (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Neuroscience and Neural Engineering (1 paper). Daniel D. Bravo is often cited by papers focused on Phagocytosis and Immune Regulation (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Neuroscience and Neural Engineering (1 paper). Daniel D. Bravo collaborates with scholars based in United States, United Kingdom and France. Daniel D. Bravo's co-authors include Jianyong Wang, T. Noelle Lombana, Julie A. Zorn, Danielle Mandikian, Avinash Gill, Alberto Estevez, Tania Chernov-Rogan, Sophia Lee, C. Andrew Boswell and Wendy Sandoval and has published in prestigious journals such as The Journal of Immunology, British Journal of Pharmacology and Bioconjugate Chemistry.

In The Last Decade

Daniel D. Bravo

5 papers receiving 56 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel D. Bravo United States	3	29	27	25	7	4	5	57
Joseph C. González United States	7	19 0.7×	46 1.7×	17 0.7×	14 2.0×	6 1.5×	9	92
Teresa R. Wagner Germany	7	52 1.8×	17 0.6×	59 2.4×	15 2.1×	2 0.5×	13	119
Erin Moore United States	3	25 0.9×	27 1.0×	17 0.7×	5 0.7×	2 0.5×	4	60
Zhengbo Xue China	6	30 1.0×	11 0.4×	56 2.2×	7 1.0×	3 0.8×	7	125
Saskia Killmer Germany	5	31 1.1×	33 1.2×	23 0.9×	11 1.6×	2 0.5×	5	96
Alex van der Kooi Netherlands	5	21 0.7×	32 1.2×	31 1.2×	3 0.4×	2 0.5×	5	83
Xianghua Chai China	6	12 0.4×	35 1.3×	38 1.5×	4 0.6×	2 0.5×	14	99
Julie Laffy United Kingdom	2	37 1.3×	33 1.2×	38 1.5×	6 0.9×	1 0.3×	2	70
Hyung Joon Kwon United States	4	25 0.9×	19 0.7×	21 0.8×	26 3.7×	3 0.8×	7	61
Laurence Laigle France	4	8 0.3×	23 0.9×	27 1.1×	6 0.9×	2 0.5×	8	61

Countries citing papers authored by Daniel D. Bravo

Since Specialization

Citations

This map shows the geographic impact of Daniel D. Bravo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Bravo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Bravo more than expected).

Fields of papers citing papers by Daniel D. Bravo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D. Bravo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Bravo. The network helps show where Daniel D. Bravo may publish in the future.

Co-authorship network of co-authors of Daniel D. Bravo

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel D. Bravo. A scholar is included among the top collaborators of Daniel D. Bravo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel D. Bravo. Daniel D. Bravo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Doan, Alexander, Elaine Mai, Daniel D. Bravo, et al.. (2023). A novel, label‐free, pre‐equilibrium assay to determine the association and dissociation rate constants of therapeutic antibodies on living cells. British Journal of Pharmacology. 181(20). 3836–3855. 1 indexed citations

2.

Bravo, Daniel D., Yongchang Shi, Wei‐Ching Liang, et al.. (2023). A Real-Time Image-Based Efferocytosis Assay for the Discovery of Functionally Inhibitory Anti-MerTK Antibodies. The Journal of Immunology. 210(8). 1166–1176. 7 indexed citations

3.

Vollmar, Breanna S., Mingjian Fei, Wei‐Ching Liang, et al.. (2022). PEGylation of anti-MerTK Antibody Modulates Ocular Biodistribution. Bioconjugate Chemistry. 33(10). 1837–1851. 1 indexed citations

4.

Lombana, T. Noelle, Sharmila Rajan, Julie A. Zorn, et al.. (2019). Production, characterization, andin vivohalf-life extension of polymeric IgA molecules in mice. mAbs. 11(6). 1122–1138. 40 indexed citations

5.

Bravo, Daniel D., Tania Chernov-Rogan, Jun Chen, & Jianyong Wang. (2017). An impedance-based cell contraction assay using human primary smooth muscle cells and fibroblasts. Journal of Pharmacological and Toxicological Methods. 89. 47–53. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact